Literature DB >> 2554347

The effects of adrenalectomy, corticotropin releasing factor and vasopressin on the sympathetic firing rate of nerves to interscapular brown adipose tissue in the Zucker rat.

S J Holt1, D A York.   

Abstract

The firing rate of the sympathetic efferent nerves to interscapular brown adipose tissue (IBAT) is lower in the obese rat compared with the lean rat. The present experiments show that adrenalectomy has no effect on nerve firing rate in the lean rat and a small but statistically nonsignificant effect in the obese rat. Injection of corticotropin releasing factor (CRF) into the IIIrd ventricle produced a dose dependent increase in the firing rate of the sympathetic nerves to interscapular brown adipose tissue (IBAT) in both lean and obese rats. The basal (unstimulated) level of firing was lower in the obese rat compared with the lean rat and remained significantly below lean values at each dose. The minimum dose of CRF to see an effect (125 ng) and the dose at which maximum effect on nerve firing rate was observed (500 ng) was similar in both genotypes. Injection of adrenocorticotropic hormone (ACTH) had no effect on nerve firing rate to IBAT. Central administration of vasopressin produced a significant increase in sympathetic firing rate to IBAT in both lean and obese rats. The temperature of IBAT was also significantly increased with vasopressin and the duration of the response was longer compared with CRF, but the minimum dose to see an effect was higher (2.5 micrograms). The response to vasopressin was greater in the obese rat compared with the lean rat but the maximum firing rate did not achieve levels observed in lean rats. Chronic infusion of CRF into the IIIrd ventricle of obese rats resulted in a reduction of food intake and body weight gain but IBAT mitochondrial GDP binding was unaltered by the treatment. These data are consistent with the hypothesis that the defect in the obese Zucker rat may be due to a glucocorticoid inhibition of CRF and/or vasopressin action in the CNS.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554347     DOI: 10.1016/0031-9384(89)90098-x

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  4 in total

1.  Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge.

Authors:  A C Linthorst; C Flachskamm; S J Hopkins; M E Hoadley; M S Labeur; F Holsboer; J M Reul
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

2.  Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal.

Authors:  S C Heinrichs; J Lapsansky; D P Behan; R K Chan; P E Sawchenko; M Lorang; N Ling; W W Vale; E B De Souza
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

Review 3.  A diurnal rhythm of stimulatory input to the hypothalamo-pituitary-adrenal system as revealed by timed intrahypothalamic administration of the vasopressin V1 antagonist.

Authors:  A Kalsbeek; J J van Heerikhuize; J Wortel; R M Buijs
Journal:  J Neurosci       Date:  1996-09-01       Impact factor: 6.167

4.  Effect of adrenalectomy on the development of a pancreatic islet lesion in fa/fa rats.

Authors:  M T Kibenge; C B Chan
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.